Beam Therapeutics Inc. (BEAM) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Beam Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Beam Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $29.3 M, a 22.4% increase year-over-year.
  • Beam Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $104 M, a 15.3% increase year-over-year.
  • Beam Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $98.6 M, a 17% increase from 2022.
  • Beam Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $84.3 M, a 93.5% increase from 2021.
  • Beam Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $43.6 M, a 183% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $104 M $29.3 M +$5.36 M +22.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $98.6 M $22.6 M +$118 K +0.52% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $98.5 M $25.8 M +$3.63 M +16.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $94.9 M $26.3 M +$4.7 M +21.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $90.2 M $23.9 M +$5.88 M +32.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $84.3 M $22.5 M +$7 M +45.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $77.3 M $22.2 M +$9.24 M +71.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $68.1 M $21.6 M +$11.1 M +106% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $57 M $18 M +$13.4 M +288% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $43.6 M $15.5 M +$8.7 M +128% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $34.9 M $13 M +$9.96 M +331% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $24.9 M $10.5 M +$7.68 M +277% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $17.2 M $4.65 M +$1.86 M +66.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $15.4 M $6.81 M +$4.75 M +231% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $10.6 M $3.01 M +$983 K +48.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $9.65 M $2.77 M +$696 K +33.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $8.95 M $2.79 M +$1.92 M +221% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $7.03 M $2.06 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $2.03 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $2.07 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $869 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.